32,939 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Purchased by Wealthfront Advisers LLC

Wealthfront Advisers LLC acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 32,939 shares of the company’s stock, valued at approximately $1,306,000.

Other institutional investors have also added to or reduced their stakes in the company. Lindbrook Capital LLC lifted its holdings in Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after acquiring an additional 345 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after acquiring an additional 301 shares in the last quarter. Fifth Third Bancorp raised its holdings in shares of Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after acquiring an additional 454 shares in the last quarter. Finally, Assetmark Inc. raised its holdings in shares of Acadia Healthcare by 66.1% in the 3rd quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock valued at $94,000 after acquiring an additional 591 shares in the last quarter.

Acadia Healthcare Price Performance

ACHC opened at $28.54 on Friday. The stock’s 50 day simple moving average is $40.15 and its 200 day simple moving average is $48.52. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare Company, Inc. has a 1 year low of $27.61 and a 1 year high of $82.40. The firm has a market cap of $2.65 billion, a price-to-earnings ratio of 9.36, a PEG ratio of 1.46 and a beta of 1.38.

Analyst Ratings Changes

ACHC has been the topic of several recent analyst reports. Bank of America lowered their price target on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a report on Tuesday, December 10th. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. KeyCorp reduced their price objective on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Monday, March 3rd. Finally, Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price objective for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $56.31.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.